A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Abroad (travel likely)RecruitingPHASE3

Conditions

Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Affiliation: Peking University Third Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Yida Tang, PhD) · tang_yida@163.com · 13901010211
  • Affiliation: Peking University Third Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Yida Tang, PhD) · tang_yida@163.com · 13901010211